Are there mild and serious metabolic syndromes? the need for a graded diagnosis

Journal of Cardiovascular Medicine

Volumn 15, Issue 10, 2014, Pages 759-760

  Cicero, Arrigo F G ^a   Derosa, Giuseppe ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

cardiovascular disease risk; metabolic syndrome; prognosis

Indexed keywords

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PHENOTYPE; REVIEW; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE; ADULT; CARDIOVASCULAR DISEASES; CLASSIFICATION; COMPLICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84906817939     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000169     Document Type: Review

References (16)

1. Koumaras C, Katsiki N, Athyros VG, Karagiannis A. Metabolic syndrome and arterial stiffness: the past, the present and the future. J Cardiovasc Med 2013; 14:687-689.
2. Ford ES, Giles WH, Dietz WH. Prevalence of metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359.
3. Cicero AFG, Nascetti S, Noera G, Gaddi AV, Massa Lombarda Project Team. Metabolic syndrome prevalence in Italy. Nutr Metab Cardiovasc Dis 2006; 16:e5-e6.
4. Mottillo S, Filion J, Genest K, et al. The metabolic syndrome and cardiovascular risk. J Am Coll Cardiol 2010; 56:1113-1132.
5. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolicsyndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
6. Kylin E. Studies on hypertension-hyperglycaemia-hyperuricemia syndrome. Zentralblatt fuer Innere Medizin 1923; 44:105-127.
7. Avogaro P, Crepaldi G, Enzi G, et al. Association of hyperlipidemia, diabetes mellitus and moderate obesity. Acta Diabetol Lat 1967; 4:36-41.
8. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
9. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51:931-938.
10. Cicero AF, Magni P, Moré M, et al. Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the Brisighella Heart Study. Int J Endocrinol 2011; 2011:724816.
11. Cicero AF, DAddato S, Reggi A, et al. Brisighella Heart Study. Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolicsyndrome in the historical cohort of the Brisighella Heart Study. Metab Syndr Relat Disord 2013; 11:412-416.
12. Yki-Järvinen H. Nonalcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014; [Epub ahead of print]. doi: 10.1016/S2213-8587(14)70032-4.
13. Antonini-Canterin F, Mateescu AD, Vriz O, et al. Impact of metabolic syndrome traits on cardiovascular function: should the Adult Treatment Panel III definition be further stratified? J Cardiovasc Med 2014; 15:752-758.
14. Bellis A, Trimarco B. Pharmacological approach to cardiovascular risk in metabolic syndrome. J Cardiovasc Med 2013; 14:403-409.
15. Cicero AF, Derosa G, Maffioli P, et al. Influence of metabolic syndrome superposition on familial combined hyperlipoproteinemia cardiovascular complication rate. Arch Med Sci 2013; 9:238-242.
16. Ertek S, Cicero AF, Cesur M, et al. The severity of coronary atherosclerosis in diabetic and nondiabetic metabolic syndrome patients diagnosed according to different criteria and undergoing elective angiography. Acta Diabetol 2011; 48:21-27.